Abstract A203: Heterogeneous nuclear ribonucleoprotein K (hnRNP K) binds to the vascular endothelial growth factor (VEGF) promoter and plays a role in its transcriptional control

Growth Factor ◽

Transcriptional Control ◽

Vascular Endothelial ◽

Hnrnp K ◽

Heterogeneous Nuclear Ribonucleoprotein ◽

Nuclear Ribonucleoprotein ◽

Regulation of Human Vascular Endothelial Growth Factor mRNA Stability in Hypoxia by Heterogeneous Nuclear Ribonucleoprotein L

Journal of Biological Chemistry ◽

10.1074/jbc.274.3.1359 ◽

1999 ◽

Vol 274 (3) ◽

pp. 1359-1365 ◽

Cited By ~ 144

Author(s):

Shu-Ching Shih ◽

Kevin P. Claffey

Keyword(s):

Growth Factor ◽

Mrna Stability ◽

Vascular Endothelial ◽

Heterogeneous Nuclear Ribonucleoprotein ◽

Nuclear Ribonucleoprotein ◽

Heterogeneous Nuclear Ribonucleoprotein K and Nucleolin as Transcriptional Activators of the Vascular Endothelial Growth Factor Promoter through Interaction with Secondary DNA Structures

Biochemistry ◽

10.1021/bi101633b ◽

2011 ◽

Vol 50 (18) ◽

pp. 3796-3806 ◽

Cited By ~ 64

Author(s):

Diana J. Uribe ◽

Kexiao Guo ◽

Yoon-Joo Shin ◽

Daekyu Sun

Keyword(s):

Growth Factor ◽

Vascular Endothelial ◽

Transcriptional Activators ◽

Dna Structures ◽

Heterogeneous Nuclear Ribonucleoprotein ◽

Secondary Dna Structures ◽

Nuclear Ribonucleoprotein ◽

P1737 Transcriptional control of telomerase reverse transcriptase in normal endothelial cells. Differences between stimulation by fibroblast growth factor-2 and vascular endothelial growth factor

European Heart Journal ◽

10.1016/s0195-668x(03)94875-5 ◽

2003 ◽

Vol 24 (5) ◽

pp. 331

Author(s):

E TRIVIER

Keyword(s):

Endothelial Cells ◽

Growth Factor ◽

Fibroblast Growth Factor ◽

Transcriptional Control ◽

Fibroblast Growth Factor 2 ◽

Telomerase Reverse Transcriptase ◽

Vascular Endothelial ◽

Fibroblast Growth ◽

Post-transcriptional control of expression of sFlt-1, an endogenous inhibitor of vascular endothelial growth factor

Journal of Cellular Biochemistry ◽

10.1002/jcb.20142 ◽

2004 ◽

Vol 93 (1) ◽

pp. 120-132 ◽

Cited By ~ 28

Author(s):

William R. Huckle ◽

Rebecca I. Roche

Keyword(s):

Growth Factor ◽

Transcriptional Control ◽

Vascular Endothelial ◽

Endogenous Inhibitor ◽

Endothelial Growth Factor ◽

Control Of Expression

Post-transcriptional control of Amblyomin-X on secretion of vascular endothelial growth factor and expression of adhesion molecules in endothelial cells

Toxicon ◽

10.1016/j.toxicon.2015.04.002 ◽

2015 ◽

Vol 101 ◽

pp. 1-10 ◽

Cited By ~ 7

Author(s):

C.C. Drewes ◽

R.Y. Dias ◽

V.G. Branco ◽

M.F. Cavalcante ◽

J.G. Souza ◽

...

Keyword(s):

Endothelial Cells ◽

Growth Factor ◽

Adhesion Molecules ◽

Transcriptional Control ◽

Vascular Endothelial ◽

Circulating vascular endothelial growth factor in patients with head and neck squamous cell carcinoma

Clinical Otolaryngology ◽

10.1046/j.1365-2273.1999.00254-10.x ◽

1999 ◽

Vol 24 (4) ◽

pp. 377-383

Author(s):

J. J. Homer ◽

J. Greenman ◽

S. R. Ell ◽

N. D. Stafford

Keyword(s):

Squamous Cell Carcinoma ◽

Growth Factor ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Neck Squamous Cell Carcinoma ◽

Vascular Endothelial ◽

Long-Term Stability of Anti-Vascular Endothelial Growth Factor (a-VEGF) Biologics Under Physiologically Relevant Conditions and Its Impact on the Development of Long-Acting Delivery Systems

Journal of Pharmaceutical Sciences ◽

10.1016/j.xphs.2020.09.043 ◽

2020 ◽

Author(s):

Debby P. Chang ◽

Shalini Burra ◽

Eric S. Day ◽

Joyce Chan ◽

Laetitia Comps-Agrar ◽

...

Keyword(s):

Growth Factor ◽

Delivery Systems ◽

Vascular Endothelial ◽

Term Stability ◽

Long Term Stability ◽

Long Acting ◽

Vascular endothelial growth factor-C (VEGF-C) overexpression is correlated with poor prognosis in intrahepatic cholangiocarcinoma (CCC)

Gastroenterology ◽

10.1016/s0016-5085(01)81291-9 ◽

2001 ◽

Vol 120 (5) ◽

pp. A261-A261 ◽

Cited By ~ 1

Author(s):

Y PAIK ◽

Y KIM ◽

S PARK ◽

J CHUNG ◽

...

Keyword(s):

Growth Factor ◽

Intrahepatic Cholangiocarcinoma ◽

Poor Prognosis ◽

Vascular Endothelial ◽

Factor C ◽

361: Serum Levels of Angiogenin and Vascular Endothelial Growth Factor (VEGF) Predict Metastatic Disease in Renal Cell Cancer Patients

The Journal of Urology ◽

10.1016/s0022-5347(18)34614-7 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 99-99 ◽

Cited By ~ 1

Author(s):

Marcus Horstmann ◽

Axel S. Merseburger ◽

Markus A. Kuczyk ◽

Arnulf Stenzl ◽

Karl-Horst Bichler ◽

...

Keyword(s):

Growth Factor ◽

Cancer Patients ◽

Renal Cell Cancer ◽

Metastatic Disease ◽

Renal Cell ◽

Cell Cancer ◽

Serum Levels ◽

Vascular Endothelial ◽

359: Serum Levels of Vascular Endothelial Growth Factor (VEGF) and Endostatin in Renal Cell Carcinoma Patients Compared to a Control Group

The Journal of Urology ◽

10.1016/s0022-5347(18)34612-3 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 98-98

Author(s):

Richard E. Zigeuner ◽

Cord Langner ◽

Peter Rehak ◽

Marco Auprich ◽

Katja Lipsky ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Cell Carcinoma ◽

Renal Cell ◽

Serum Levels ◽

Control Group ◽

Vascular Endothelial ◽